We helped transform a company with diverse clinical and commercial assets into a focused, specialty pharma.

To achieve this, we:

built a bespoke business model based on analysis of the client’s portfolio and commercial strengths;

identified viable alternative growth scenarios,  and evaluated risk and value implications of each;

worked with the Board of Directors to agree a major corporate transformation plan.


To receive details of new white papers and events please enter your details below

Click here if you would like to receive emails from us. Read our privacy policy

Newsletter Signup